Biosimilar Growth Hormones Market Segments 2024-2033: Size, Share, and Insights

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Biosimilar Growth Hormones Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $1.19 billion In 2028 At A CAGR Of 9.8% :

The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for growth hormones, patent expirations, clinical evidence, increasing clinical trials.

The biosimilar growth hormones market size is expected to see strongly grown in the next few years. It will grow to $1.19 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to pediatric growth disorders, expanding indications,increase in the diagnosis, increased awareness biosimilar options. Major trends in the forecast period include pediatric-focused biosimilars, biosimilar combinations, dosing convenience, biosimilar combinations, dosing convenience.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

Biosimilar Growth Hormones Market Major Segments
The biosimilar growth hormones market covered in this report is segmented -

1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics

Key Driver - Rising Incidence Of Childhood Growth Hormone Deficiency Spurs Global Biosimilar Growth Hormone Market

The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market. Growth hormone deficiency is caused by damage to the pituitary gland or hypothalamus, which may be the result of an abnormal formation that occurred before the child was born (congenital) or something that occurred during or after birth (acquired). Growth hormone deficiency has been identified in about 1 in every 3,800 babies. Additionally, some children acquire it later in life as a result of a brain tumor, brain operation, radiation therapy, injury, or infection. Thus, an increase in the number of children suffering from growth deficiencies drives the growth of the biosimilar growth hormones industry.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=3391&type=smp

Prominent Trend - Advancements In Rdna Technology Transforming Biosimilar Growth Hormone Production For Greater Affordability

Recombinant DNA technology (rDNA technology) is increasingly being implemented in the biosimilar growth hormone industry. The development of biosimilar growth hormone by using recombinant DNA technology (rDNA technology) is an emerging trend. For instance, in February 2021, Pfizer Inc., a US-based pharmaceutical company announced the initiation of Phase III clinical trial to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with Prader-Willi Syndrome (PWS). Somatropin, a growth hormone, is administered to address growth hormone deficiency (GHD) in children. The trial, on the other hand, is a multicenter, open-label, multi-cohort study.

Biosimilar Growth Hormones Market Players
Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Coherus BioSciences Inc., Daiichi Sankyo Company Ltd., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., GenScript Biotech Corporation, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Oncobiologics Inc., Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the biosimilar growth hormone market in 2023. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biosimilar Growth Hormones Market Report Structure
3. Biosimilar Growth Hormones Market Trends And Strategies
4. Biosimilar Growth Hormones Market - Macro Economic Scenario
5. Biosimilar Growth Hormones Market Size And Growth
…..
27. Biosimilar Growth Hormones Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.